If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMADE.L Regulatory News (MADE)

  • There is currently no data for MADE

Stabilisation Notice

30 Jun 2021 07:00

RNS Number : 5389D
J.P. Morgan Securities PLC.
30 June 2021
 

 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO OR FROM THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE UNLAWFUL.

 

Made.com Group Plc

Notice of Stabilisation

Made.com Group Plc hereby gives notice that J.P. Morgan Securities plc (which conducts its UK investment banking activity as J.P. Morgan Cazenove) has undertaken stabilisation within the meaning of Article 3.2(d) of the Regulation (EU) No 596/2014 (Market Abuse Regulation) and the delegated acts, implementing acts, and technical standards and guidelines thereunder as such legislation forms part of retained EU law by virtue of the European Union (Withdrawal) Act 2018 and Commission Delegated Regulation (EU) 2016/1052 as it forms part of retained EU law by virtue of the European Union (Withdrawal) Act 2018.

The securities:

 

Issuer:

 

Made.com Group Plc

Shares:

 

Ordinary Shares of £0.0001 each (ISIN: GB00BNXM7M46)

 

Offering size:

 

96,915,044 Ordinary Shares excluding Over-allotment Option

Description:

Initial Public Offering of Ordinary Shares

 

Offer price:

 

200p per Ordinary Share

Stabilisation:

 

Stabilising Manager (and central point within the meaning of Commission Delegated Regulation 2016/1052 as it forms part of retained EU law by virtue of the European Union (Withdrawal) Act 2018):

 

J.P. Morgan Securities plc (which conducts its UK investment banking activity as J.P. Morgan Cazenove)

25 Bank Street, Canary Wharf, London, E14 5JP, United Kingdom

Contact: Beau Freker; telephone: +44 207 742 4000

 

 

 

Beginning of the stabilisation period:

 

16 June 2021

Stabilisation period to end no later than:

 

15 July 2021

Trading venue where stabilisation may be undertaken:

 

London Stock Exchange

Maximum size and conditions of use of Over-allotment Option:

 

The Stabilising Manager may over-allot the securities to the extent permitted in accordance with applicable law, up to the maximum size of 14,537,257 Ordinary Shares

For each of the dates during which stabilisation transactions were carried out, the price range was as follows:

Execution Date

Lowest Price

Highest Price

Trading Venue

25 June 2021

199.8000

200.0000

XLON

 

Disclaimer

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement is not for release, publication or distribution, directly or indirectly, in or into the United States of America (the "United States"), Australia, Canada, Japan or any other jurisdiction where such release, publication or distribution would be unlawful. This announcement does not contain or constitute, or form part of, an offer to sell, or a solicitation of an offer to purchase, any securities in the United States, Australia, Canada, Japan or any other jurisdiction where such an offer would be unlawful.

The securities discussed herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or with any securities regulatory authority of any state or other jurisdiction of the United States. The securities may not be offered, sold, resold, transferred or delivered, directly or indirectly, within the United States except pursuant to an applicable exemption from or in a transaction not subject to the registration requirements of the Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction of the United States. No public offering of the securities discussed herein is being made in the United States. The securities referred to herein have not been registered under the applicable securities laws of Australia, Canada or Japan and, subject to certain exceptions, may not be offered or sold within Australia, Canada or Japan or to any national, resident or citizen of Australia, Canada or Japan. The release, publication or distribution of this announcement in other jurisdictions may be restricted by law and persons into whose possession this announcement comes should inform themselves about, and observe, such restrictions.

 

This announcement is only addressed to and directed at specific addressees who: (A) if in member states of the European Economic Area (the "EEA"), are persons who are "qualified investors" within the meaning of Article 2(e) of Regulation (EU) 2017/1129 (as amended) ("Qualified Investors"); and (B) if in the United Kingdom, are "qualified investors" within the meaning of Article 2(e) of Regulation (EU) 2017/1129 (as amended) as it forms part of retained EU law by virtue of the European Union (Withdrawal) Act 2018 who are: (i) persons having professional experience in matters relating to investments who fall within the definition of "investment professionals" in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order"); or (ii) high net worth entities falling within Article 49(2)(a) to (d) of the Order; or (C) are other persons to whom it may otherwise lawfully be communicated (all such persons referred to in (B) and (C) together being "Relevant Persons"). This announcement must not be acted or relied on (i) in the United Kingdom, by persons who are not Relevant Persons and (ii) in any member state of the EEA by persons who are not Qualified Investors. Any investment activity to which this announcement relates (i) in the United Kingdom is available only to, and may be engaged in only with, Relevant Persons; and (ii) in any member state of the EEA is available only to, and may be engaged only with, Qualified Investors.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STAEASKNAFEFEFA
Date   Source Headline
5th Oct 202210:56 amRNSForm 8.5 (EPT/RI) - Made.com Group plc
5th Oct 202210:28 amRNSForm 8.3 - Made.com
5th Oct 202210:13 amRNSForm 8.3 - MADE.COM
5th Oct 20228:55 amRNSForm 8.5 (EPT/RI)
4th Oct 20226:29 pmRNSForm 8.3 - Made.com Group Plc
4th Oct 202211:49 amRNSForm 8.3 - Made.com Group Plc
4th Oct 202210:48 amRNSForm 8.5 (EPT/RI) - Made.com Group plc
4th Oct 20228:29 amRNSForm 8.5 (EPT/RI)
4th Oct 20227:00 amRNSUpdate on Formal Sale Process and Timetable
3rd Oct 20224:05 pmRNSForm 8.3 - made.com
3rd Oct 20221:10 pmRNSForm 8.3 - MADE.COM GROUP PLC
3rd Oct 202211:40 amRNSForm 8.3 - Made.com
3rd Oct 202210:26 amRNSForm 8.5 (EPT/RI) - Made.com Group plc
3rd Oct 20228:41 amRNSForm 8.5 (EPT/RI) - Made.com Group Plc
30th Sep 202212:43 pmRNSForm 8.3 - MADE.COM GROUP PLC
30th Sep 202210:41 amRNSForm 8.5 (EPT/RI) - Made.com Group plc
30th Sep 20228:53 amRNSForm 8.5 (EPT/RI)
29th Sep 20224:41 pmRNSSecond Price Monitoring Extn
29th Sep 20224:37 pmRNSPrice Monitoring Extension
29th Sep 20223:05 pmRNSInterim Results for the six months to 30 June 2022
29th Sep 20222:17 pmRNSForm 8.3 - Made.com Group Plc
29th Sep 20222:06 pmRNSForm 8.3 - Made.com Group Plc
29th Sep 20222:03 pmRNSForm 8.3 - MADE.COM GROUP PLC
29th Sep 202210:34 amRNSForm 8.5 (EPT/RI) - Made.com Group plc
29th Sep 202210:34 amRNSForm 8.3 - Made.com Group Plc
29th Sep 20228:53 amRNSForm 8.5 (EPT/RI)
28th Sep 20222:13 pmRNSForm 8.3 - MADE.COM GROUP PLC
28th Sep 202210:54 amRNSForm 8.5 (EPT/RI) - Made.com Group plc
28th Sep 20228:45 amRNSForm 8.5 (EPT/RI)
27th Sep 20224:59 pmRNSForm 8.3 - Made.com group plc
27th Sep 20222:06 pmRNSForm 8.3 - MADE.COM GROUP PLC
27th Sep 202210:46 amRNSForm 8.5 (EPT/RI)-Made.com Group plc
27th Sep 20228:48 amRNSForm 8.5 (EPT/RI)
26th Sep 20223:04 pmRNSForm 8.3 - MADE.COM GROUP PLC
26th Sep 20222:46 pmRNSForm 8.3 - MADE.COM GROUP PLC
26th Sep 202210:44 amRNSForm 8.5 (EPT/RI) - Made.com Group plc
26th Sep 202210:24 amRNSForm 8.3 - [Made.com Group Plc]
26th Sep 20229:35 amRNSForm 8.5 (EPT/RI)
23rd Sep 20227:00 amRNSStrategic Review and Formal Sale Process
23rd Sep 20227:00 amRNSStrategic Review and Formal Sale Process
22nd Aug 20227:00 amRNSDirectorate Change
18th Aug 20227:00 amRNSResponse to press speculation
15th Aug 20224:32 pmRNSHolding(s) in Company
3rd Aug 202212:00 pmRNSHolding(s) in Company
26th Jul 20223:00 pmRNSHolding(s) in Company
19th Jul 20227:00 amRNSQ2 TRADING UPDATE AND REVISED GUIDANCE
30th Jun 20224:30 pmRNSTotal Voting Rights
29th Jun 20224:00 pmRNSDirector/PDMR Shareholding
27th Jun 20221:47 pmRNSDirector/PDMR Shareholding
22nd Jun 202210:56 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.